MAP infections are usually acquired during calf hood via the ingestion of contaminated colostrum, milk, feed and water, and fecal shedding of organisms by infected cattle usually starts around 2 years of age (Sweeny, 1996) . Reportedly, the prevalence of MAP infection in US dairy herds ranges from 20 to 40% and costs to the dairy industry are estimated at $220 million annually. In addition to the direct losses, the need for premature culling of MAP-infected animals reduces the herd manager's ability to cull for other health-related problems and low productivity in terms of weight loss and milk yield. Johne's disease is endemic in developing and developed countries (Abbas et al., 2011) .
The control and eradication of Johne's disease has been mainly hampered by the non-availability of suitable methods that can detect animals in early stages of infection. Paratuberculosis is difficult to diagnose in animals that have no clinical signs. Clinical signs of the disease do not typically develop for several years after initial infection because of the slow growing nature of the organism and the change to humoral immunity from cell-mediated immunity during the late stage of infection. At this stage of infection, organisms may be present in the faeces in insufficient numbers to be detected by current culture methods. In addition, animals in the early stages of infection often do not elicit an immune response that is detectable by current tests.
Need for Vaccination for Johne's Disease
In endemic areas, animals are exposed daily to MAP from the contaminated environment, but animals younger than 6 months, with a functionally immature immune system, are particularly susceptible to MAP (Larsen et al., 1975) and will become infected during the first months of life by ingestion of contaminated colostrum, milk, water and feed (Sweeney, 1996) . The immune system of the newborn has a strong tendency to adopt a Th2-type profile, whereas a Th1-type profile is thought to be essential for protection against intracellular pathogens, such as mycobacteria. Vaccination of dams may represent an alternative approach in the control of infection of newborns.
Johne's Disease Vaccines
Vaccination against MAP was first reported in 1926 by Vallée and Rinjard. Their vaccine consisted of a live non-virulent strain of MAP adjuvanted in a mix of olive oil, liquid paraffin and pumice powder. Now days, a number of live-attenuated and killed whole-cell-based vaccines were developed both for bovine and ovine Johne's disease which are suspended in mineral oil, are inoculated subcutaneously in cattle within 30 days of birth in the brisket (Bakker et al., 2000) . In goats, sheep and deer, vaccines are generally injected in the neck behind the ear (Gilmour, 1976) .
Types of Vaccines

A. Killed whole-cell-based vaccines
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Mycopar is a commercial vaccine in USA developed from Strain 18 and is actually composed of killed M. avium subsp. avium helps in increasing antibody response against MAP and prevented further infection but causes interference in ELISA results (Chiodini,1993; Spangler et al., 1991) . "Lelystad" vaccine, manufactured in Netherlands, is composed of heat-killed MAP bacteria suspended in a water-oil emulsion and "Gudair" vaccine from strain 316 F developed in Spain are found to increase IFN-γ production 
C. Subunit Based Vaccines
The three members of the Ag85 complex are highly conserved proteins with mycolyl-transferase activity present in all mycobacterial species and abundantly secreted in mycobacterial culture filtrate. The Ag85A 
